Evidence map›Paper›PMID 23466689›Full record

ArticleBehavioural brain research2013

Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana.

Young-Hoon Sung, Paul D Carey, Dan J Stein, Helen L Ferrett, Bruce S Spottiswoode, Perry F Renshaw, Deborah A Yurgelun-Todd

Abstract read
In one paragraph

Article in Behavioural brain research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Young-Hoon SungDepartment of Psychiatry, University of Utah, Salt Lake City, UT 84108, USA.
Paul D Carey
Dan J Stein
Helen L Ferrett
Bruce S Spottiswoode
Perry F Renshaw
Deborah A Yurgelun-Todd

Funding

MRS/fMRI Investigations of Adolescent Cannabis UseR01DA020269 · NIDA · UNIVERSITY OF UTAH · PI YURGELUN-TODD, DEBORAH A. · 2007 to 2011
$1.3M
Mentoring in Drug Abuse NeuroimagingK05DA031247 · NIDA · UNIVERSITY OF UTAH · PI RENSHAW, PERRY FRANKLIN · 2011 to 2015
$661k
Brain Changes with Cannabis and MethamphetamineR21DA021422 · NIDA · UNIVERSITY OF UTAH · PI YURGELUN-TODD, DEBORAH A. · 2007 to 2008
$259k
NIDA NIH HHS 1R01 DA020269NIDA NIH HHS K05 DA031247NIDA NIH HHS R01 DA020269NIDA NIH HHS R21 DA021422
6 · The paper itself

Abstract

introductionThe potential neurochemical toxicity associated with methamphetamine (MA) or marijuana (MJ) use on the developing adolescent brain is unclear, particularly with regard to individuals with concomitant use of MA and MJ (MA+MJ). In this study, proton magnetic resonance spectroscopy (MRS) was utilized to measure in vivo brain N-acetylaspartate plus N-acetylaspartyl glutamate (tNAA, an indicator of intact neuronal integrity) levels.

methodsThree adolescent groups from Cape Town, South Africa completed MRS scans as well as clinical measures including a drug use history. Subjects included (1) nine MA (age=15.7±1.37), (2) eight MA+MJ (age=16.2±1.16) using adolescents and (3) ten healthy controls (age=16.8±0.62). Single voxel spectra were acquired from midfrontal gray matter using a point-resolved spectroscopy sequence (PRESS). The MRS data were post-processed in the fully automated approach for quantitation of metabolite ratios to phosphocreatine plus creatine (PCr+Cr).

resultsA significant reduction in frontal tNAA/PCr+Cr ratios was seen in the MA+MJ group compared to the healthy controls (p=0.01, by 7.2%) and to the MA group (p=0.04, by 6.9%). Significant relationships were also observed between decreased tNAA/PCr+Cr ratios and drug use history of MA or MJ (total cumulative lifetime dose, age of onset, and duration of MA and MJ exposure) only in the MA+MJ group (all p<0.05).

conclusionsThese findings suggest that in adolescents, concomitant heavy MA+MJ use may contribute to altered brain metabolites in frontal gray matter. The significant associations between the abnormal tNAA/PCr+Cr ratios and the drug use history suggest that MA+MJ abuse may induce neurotoxicity in a dose-responsive manner in adolescent brain.

Indexed as

AdolescentAmphetamine-Related DisordersAnalysis of VarianceAspartic AcidBrain MappingDipeptidesFemaleFrontal LobeHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMaleMarijuana SmokingProtonsRegression AnalysisAspartic AcidDipeptidesisospaglumic acidN-acetylaspartateProtons

Identifiers

PMID23466689
PMCPMC3668971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.